GlassScriptPhysician profile
Amy Y Lai
NPI 1003888157
$3,697.78
in general payments reported to CMS, 2019-2025
11 companies · $3,257 in 2025
The $3,257 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.68 · 2020: $53.56 · 2021: $131 · 2022: $41.06 · 2023: $93.22 · 2024: $92.85 · 2025: $3,257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $442.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,138.50 | 2025 | |
| Shield Therapeutics INC | $122.50 | 2024-2025 | |
| Pfizer INC. | $101.98 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $75.70 | 2023-2025 | Myfembree |
| Avion Pharmaceuticals | $66.65 | 2020-2021 | |
| Abbvie INC. | $63.39 | 2021-2023 | |
| Organon LLC | $39.48 | 2024-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $31.91 | 2019-2024 | Thinprep 2000 Processor |
| Amag Pharmaceuticals, INC. | $20.02 | 2020 | |
| Ferring Pharmaceuticals INC. | $19.42 | 2023 | Rebyota |
| Coopersurgical, INC. | $18.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Lai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.